$Cassava Sciences(SAVA.US)$Why would people choose to stay on simufilan on extended trial if the drug didn’t work on a debilitating disease such as AD? AD gets violently worse over time . There’s never been an issue of safety and patient families and doctors testimony that sava works. 1900 people on this are not going to want to get off the drug and get worse again.  The drug works

$Cassava Sciences(SAVA.US)$ If we are going by ethics and integrity, did the DOJ ever investigate this’ Eisai and Biogen’s Alzheimer’s disease drug lecanemab’? Where was the outrage, DOJ investigation and accusations by Bik, Bredt, Adrian , Jesse and Shorts over death of patients in a drug that should have never been approved? 2 years ago when CUNY, SEC and FDA investigated, they found no evidence of wrongdoing or manipulation by SAVA or Wang. DOJ on a Friday afternoon before options expires wit...

$Cassava Sciences(SAVA.US)$ Cassava Sciences Issues Statement on Former Science Advisor Jun 28, 2024:"Dr. Wang and his former public university medical school have had no involvement in the Company’s Phase 3 clinical trials of simufilam."

$Cassava Sciences(SAVA.US)$Spoke to a former Vet that is now a Doctor  about simufilam and repairing  misfolded  protein as opposed to removing plaques in the brain like all the other failed drugs that got approved that caused brain bleeding and and killed people.  He stated how bad the plaque removal is for the body and the shock it causes to your neurons. It is a recipe for disaster and death to the body. But repairing misfolded protein in the brain is like restoring energy that decayed over t...

$Cassava Sciences(SAVA.US)$ The Drug must be Working. More people signed up and more locations opened up. Today: Twelve new $SAVA trial sites added to ClinicalTrials .gov website for @CassavaSciences Phase3 Open Label Extension (since 4/24/24). New total of 95 sites now available to compassionately treating a whopping ~90% of P3 patients electing to enter #simufilam's P3-OLE!
Thanks to Archisaurus for updates

$Cassava Sciences(SAVA.US)$ New Article stating that removing the amyloid plaque is wrong with all those AD drugs that FDA approved and recently approved but later being rejected
´The amyloid hypothesis has struggled to translate into effective treatments’
This is why Filamin A , repairing the misfolded protein with SAVA  Simufilam has MOA, mechanism of acting  slows decline and improves cognition.  A treatment that actually helps with the brain in repairing it’s functions as opposed to removi...

$Cassava Sciences(SAVA.US)$ A very Good Bullish Point was Just made regarding SAVA. On a debilitating disease, There's no way that many people would waste their time, effort and chance of being properly treated if the drug didn't work and over that long period of time. Shorts have tried everything to keep the price down, keep the trials from continuing and false allegations. They have no morals but We the people and over 1900 patients that are being treated and wanted to stay on the drug further...

$Cassava Sciences(SAVA.US)$ New Analyst Upgrade to Buy SAVA. Stay Bullish my friends🚀

$Cassava Sciences(SAVA.US)$ Impressive SAVA .June 2024 Neurobiology of Disease article discloses strong support for neural circuit dysfunction being a consequence of FLNA mutations AND cites downregulating FLNA w/ SAVA - Thanks to Archisaurus Research

$Cassava Sciences(SAVA.US)$ SAVA very undervalued for being the only safest treatment of AD patients in Phase 3 trials. Making the news for its short squeeze potential